Precigen, Inc. (PGEN)
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbIL15, a gene that enhances functional characteristics of immune cells; Sleeping Beauty, a non-viral transposon/transposase system; AttSite recombinases, which breaks and rejoins DNA at specific sequences; AdenoVerse technology platform, a library of engineered adenovector serotypes; and L. lactis is a food-grade bacterium. Additionally, it provides RheoSwitch, an inducible gene switch system that provides quantitative dose-proportionate regulation of the amount and timing of target protein expression; kill switches to selectively eliminate cell therapies in vivo; tissue-specific promoters; UltraCAR-T platform for the treatment of cancer; AdenoVerse Immunotherapy, a library of proprietary adenovectors for the gene delivery; and ActoBiotics platform, genetically modified bacteria that deliver proteins and peptides at mucosal sites. Precigen, Inc. has collaboration and license agreements with Alaunos Therapeutics, Inc.; Ares Trading S.A.; Oragenics, Inc.; Castle Creek Biosciences, Inc.; Intrexon Energy Partners, LLC; and Intrexon Energy Partners II, LLC. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in January 2020. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland.
$289.50M
Dr. Helen Sabzevari MPH, Ph.D.
456.00
Germantown, MD
Aug 08, 2013
-1.86
$-0.54
0.41
1.03
-142.95%
-9.57
-1.14
6.26
15.62
1.03
-38.56%
-27.77%
Similar stocks (12)
Protagonist Therapeutics, Inc.
PTGX
Edgewise Therapeutics, Inc.
EWTX
Syndax Pharmaceuticals, Inc.
SNDX
Day One Biopharmaceuticals, Inc.
DAWN
CorMedix Inc.
CRMD
Corvus Pharmaceuticals, Inc.
CRVS
Inozyme Pharma, Inc.
INZY
Sangamo Therapeutics, Inc.
SGMO
Agenus Inc.
AGEN
Leap Therapeutics, Inc.
LPTX
Marker Therapeutics, Inc.
MRKR
Galera Therapeutics, Inc.
GRTX
ETF Exposure (29)
iShares Micro-Cap ETF
IWC
0.03302%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.024%
iShares Biotechnology ETF
IBB
0.01183%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
Vanguard Russell 2000 Value Index Fund
VTWV
0.01%
iShares Russell 2000 Value ETF
IWN
0.00858%
ProShares Ultra Nasdaq Biotechnology
BIB
0.006983844239963117%
Schwab U.S. Small-Cap ETF
SCHA
0.0058323885%
iShares Russell 2000 ETF
IWM
0.00489%
WisdomTree BioRevolution Fund
WDNA
0.0027864%
ProShares Ultra Russell2000
UWM
0.0017980326932941946%
ProShares UltraPro Russell2000
URTY
8.86400670476147e-4%
iShares Russell 2000 Growth ETF
IWO
8.3e-4%
ProShares Hedge Replication ETF
HDG
7.540389661717196e-4%
Schwab U.S. Broad Market ETF
SCHB
5.423963e-4%
iShares Russell 3000 ETF
IWV
4.1e-4%
iShares MSCI USA Small-Cap Multifactor ETF
SMLF
0%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Russell 2000 Growth Index Fund
VTWG
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (12)
Protagonist Therapeutics, Inc.
PTGX
Edgewise Therapeutics, Inc.
EWTX
Syndax Pharmaceuticals, Inc.
SNDX
Day One Biopharmaceuticals, Inc.
DAWN
CorMedix Inc.
CRMD
Corvus Pharmaceuticals, Inc.
CRVS
Inozyme Pharma, Inc.
INZY
Sangamo Therapeutics, Inc.
SGMO
Agenus Inc.
AGEN
Leap Therapeutics, Inc.
LPTX
Marker Therapeutics, Inc.
MRKR
Galera Therapeutics, Inc.
GRTX
ETF Exposure (29)
iShares Micro-Cap ETF
IWC
0.03302%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.024%
iShares Biotechnology ETF
IBB
0.01183%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
Vanguard Russell 2000 Value Index Fund
VTWV
0.01%
iShares Russell 2000 Value ETF
IWN
0.00858%
ProShares Ultra Nasdaq Biotechnology
BIB
0.006983844239963117%
Schwab U.S. Small-Cap ETF
SCHA
0.0058323885%
iShares Russell 2000 ETF
IWM
0.00489%
WisdomTree BioRevolution Fund
WDNA
0.0027864%
ProShares Ultra Russell2000
UWM
0.0017980326932941946%
ProShares UltraPro Russell2000
URTY
8.86400670476147e-4%
iShares Russell 2000 Growth ETF
IWO
8.3e-4%
ProShares Hedge Replication ETF
HDG
7.540389661717196e-4%
Schwab U.S. Broad Market ETF
SCHB
5.423963e-4%
iShares Russell 3000 ETF
IWV
4.1e-4%
iShares MSCI USA Small-Cap Multifactor ETF
SMLF
0%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Russell 2000 Growth Index Fund
VTWG
0%
Vanguard Extended Market Index Fund
VXF
0%